Nuclear Medicine Question for the Week of February 6, 2017



We inject Kinevac® (sincalide for injection) both before and after hepatobiliary scans. Can we charge for two doses, since we have to pay for two separate Kinevac® doses from our outside pharmacy?



The code description for Kinevac® is J2805—injection, sincalide, 5 micrograms. If the total amount for both injections is 5 micrograms (the dose unit) or less, then you bill J2805 x 1. If your total amount is 6–10 micrograms, then you would bill J2805 x 2.

Kinevac® (Sincalide for Injection)

Indications and Usage:
Kinevac may be used: (1) to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; (2) to stimulate pancreatic secretion (especially in conjunction with secretin) prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; (3) to accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.

Kinevac is contraindicated in patients hypersensitive to sincalide and in patients with intestinal obstruction. Because of Kinevac’s effect on smooth muscle, pregnant patients should be advised that spontaneous abortion or premature induction of labor may occur. Adverse reactions to sincalide are generally mild and of short duration. The most frequent adverse reactions were abdominal discomfort or pain, and nausea.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Kinevac is manufactured for Bracco Diagnostics Inc., Monroe Township, NJ 08831,
by Jubilant HollisterStier LLC, Spokane, WA 99207.

Kinevac is a registered trademark of Bracco Diagnostics Inc.